United States · FDA National Drug Code directory

Viri Sode

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
83027-0150_aa330e58-bbfc-474e-8d9e-31d649bfe238
Product NDC
83027-0150
Form
SPRAY
Composition / generic term
Cytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex II Nosode, Influenzinum (2024-2025), Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster Nosode
Labeler
Nutritional Specialties, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20250603 / 20300507

Source-listed ingredients

  • HUMAN HERPESVIRUS 5 — 16 [hp_X]/mL
  • HUMAN HERPESVIRUS 1 — 16 [hp_X]/mL
  • HUMAN HERPESVIRUS 2 — 16 [hp_X]/mL
  • INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) — 15 [hp_C]/mL
  • INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) — 15 [hp_C]/mL
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE — 15 [hp_C]/mL
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE — 15 [hp_C]/mL
  • RUBELLA VIRUS — 16 [hp_X]/mL
  • HEPATITIS A VIRUS — 30 [hp_X]/mL
  • HEPATITIS B VIRUS — 30 [hp_X]/mL
  • HEPATITIS C VIRUS — 30 [hp_X]/mL
  • HUMAN HERPESVIRUS 4 — 15 [hp_C]/mL
  • HUMAN HERPESVIRUS 3 — 15 [hp_C]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 60 mL in 1 BOTTLE, SPRAY (83027-0150-1) · 83027-0150-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →